| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4820e6ded4d368fa1fde368d6f96f753 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-414
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-42 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-56 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 |
| filingDate |
2014-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75a4512b92d5888ff47aaf4b1f584b9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fee52a43e1f39cff9e04f73eb2d0086f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd9a2398be011259782b8729682ba847
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8aff48f46b47d5b556cbfde153b883df |
| publicationDate |
2016-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20160036737-A |
| titleOfInvention |
Therapeutic foam scaffolds incorporating biopolymer-shelled mesoporous nanospheres with growth factors |
| abstract |
The present invention relates to a hybrid nanocarrier comprising a mesoporous silica nanosphere core having a pore size capable of supporting a drug and a biodegradable polymer shell; And a foam scaffold having a three-dimensional collagen structure filled with the nanotransporter, a method for producing the same, and a composition for drug delivery comprising the same. The hybrid silica nanospheres embedded in the foam scaffold according to the present invention have a high average pore diameter of ~12.2 nm and are shelled with polylactic acid (PLA) or polyethylene glycol (PEG) to be supported in a collagen structure, Drugs (eg, acidic fibroblast growth factor (aFGF)) can be released at a significantly sustained rate. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109896528-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108079371-A |
| priorityDate |
2014-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |